These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 32533506
1. Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset. Li S, Wang X, Zhao Y, Ji W, Mao J, Nie M, Wu X. Endocrine; 2020 Sep; 69(3):615-624. PubMed ID: 32533506 [Abstract] [Full Text] [Related]
2. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS. Lazar L, Levy S, Oron T, Meyerovitch J, de Vries L, Shalitin S, Tenenbaum A, Phillip M, Lebenthal Y. J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3287-3295. PubMed ID: 30912806 [Abstract] [Full Text] [Related]
3. Effects of different therapy regimens to increase final adult height in males at advanced bone age with idiopathic short stature. Wang W, Wang Y, Xiao Y, Cao N, Wang Y. BMC Pediatr; 2023 Dec 05; 23(1):615. PubMed ID: 38053091 [Abstract] [Full Text] [Related]
4. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Lanes R, Gunczler P. Clin Endocrinol (Oxf); 1998 Aug 05; 49(2):197-202. PubMed ID: 9828907 [Abstract] [Full Text] [Related]
5. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. Pasquino AM, Pucarelli I, Roggini M, Segni M. J Clin Endocrinol Metab; 2000 Feb 05; 85(2):619-22. PubMed ID: 10690865 [Abstract] [Full Text] [Related]
6. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height. Toumba M, Bacopoulou I, Savva SC, Skordis N. Indian Pediatr; 2007 Jul 05; 44(7):497-502. PubMed ID: 17684302 [Abstract] [Full Text] [Related]
9. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential. Toumba M, Kokotsis V, Savva SC, Skordis N. J Pediatr Endocrinol Metab; 2014 Mar 05; 27(3-4):311-6. PubMed ID: 24158419 [Abstract] [Full Text] [Related]
10. A pilot study of growth hormone administration in boys with predicted adult short stature and near-ending growth. Rothenbuhler A, Ormières B, Kalifa G, Bougnères P. Growth Horm IGF Res; 2015 Apr 05; 25(2):96-102. PubMed ID: 25641639 [Abstract] [Full Text] [Related]
11. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency. Scalco RC, Melo SS, Pugliese-Pires PN, Funari MF, Nishi MY, Arnhold IJ, Mendonca BB, Jorge AA. J Clin Endocrinol Metab; 2010 Jan 05; 95(1):328-32. PubMed ID: 19926713 [Abstract] [Full Text] [Related]
12. A meta-analysis of combination therapy with gonadotrophin-releasing hormone agonist and growth hormone for children with idiopathic short stature and normal timed puberty. Zhou B, Liu S, Wang J, Zhang T, Yuan Y, Niu W, Zhang Z, Wang L. Endocrine; 2022 Mar 05; 75(3):698-708. PubMed ID: 35083638 [Abstract] [Full Text] [Related]
14. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa. van der Steen M, Lem AJ, van der Kaay DC, Hokken-Koèelega AC. J Clin Endocrinol Metab; 2016 May 05; 101(5):2005-12. PubMed ID: 26964733 [Abstract] [Full Text] [Related]
15. [Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty]. Wang CL, Liang L, Liu PN, Jin XJ, Chen LQ, Yang F, Lian Q, Chen RM. Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan 05; 16(1):25-30. PubMed ID: 24461173 [Abstract] [Full Text] [Related]
16. Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height. Dotremont H, France A, Heinrichs C, Tenoutasse S, Brachet C, Cools M, De Waele K, Massa G, Lebrethon MC, Gies I, Van Besien J, Derycke C, Ziraldo M, De Schepper J, Beauloye V, Verhulst S, Rooman R, den Brinker M. Front Endocrinol (Lausanne); 2023 Jan 05; 14():1113750. PubMed ID: 37008942 [Abstract] [Full Text] [Related]
17. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone? Colmenares A, González L, Gunczler P, Lanes R. J Pediatr Endocrinol Metab; 2012 Jan 05; 25(7-8):651-7. PubMed ID: 23155689 [Abstract] [Full Text] [Related]
18. Should Skeletal Maturation Be Manipulated for Extra Height Gain? Wit JM. Front Endocrinol (Lausanne); 2021 Jan 05; 12():812196. PubMed ID: 34975773 [Abstract] [Full Text] [Related]
19. Adding Letrozole to Growth Hormone and Gonadotropin-Releasing Hormone Analog Increases Height in Girls With Short Stature: A Hospital Record-Based Retrospective Study. Li C, Wang X, Nie M, Mao J, Wu X. Endocr Pract; 2024 Jul 05; 30(7):639-646. PubMed ID: 38723894 [Abstract] [Full Text] [Related]
20. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center. Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT. Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]